Have a feature idea you'd love to see implemented?
Let us know!
EVH Evolent Health Inc
Price (delayed)
$11.59
Market cap
$1.35B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.92
Enterprise value
$1.89B
Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care
Highlights
Evolent Health's net income has increased by 40% YoY and by 3.6% QoQ
The revenue has grown by 38% YoY and by 4.7% from the previous quarter
The gross margin has contracted by 35% YoY and by 14% from the previous quarter
EVH's gross profit is down by 11% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of EVH
Market
Valuations
Earnings
Shares outstanding
116.56M
Market cap
$1.35B
Enterprise value
$1.89B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.3
Price to sales (P/S)
0.54
EV/EBIT
N/A
EV/EBITDA
25.2
EV/Sales
0.77
Revenue
$2.46B
EBIT
-$43.68M
EBITDA
$74.99M
Free cash flow
$109.58M
Per share
Balance sheet
Liquidity
EPS
-$0.92
Free cash flow per share
$0.95
Book value per share
$8.93
Revenue per share
$21.45
TBVPS
$5.81
Total assets
$2.5B
Total liabilities
$1.28B
Debt
$635.21M
Equity
$1.04B
Working capital
$20.33M
Debt to equity
0.61
Current ratio
1.04
Quick ratio
0.99
Net debt/EBITDA
7.18
Margins
Efficiency
Dividend
EBITDA margin
3%
Gross margin
16%
Net margin
-2.4%
Operating margin
-1.1%
Return on assets
-4%
Return on equity
-9.5%
Return on invested capital
-6.8%
Return on capital employed
-2.2%
Return on sales
-1.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EVH stock price
How has the Evolent Health stock price performed over time
Intraday
2.48%
1 week
-8.52%
1 month
-50.02%
1 year
-59.71%
YTD
-64.91%
QTD
-59.02%
Financial performance
How have Evolent Health's revenue and profit performed over time
Revenue
$2.46B
Gross profit
$393.27M
Operating income
-$28.19M
Net income
-$58.98M
Gross margin
16%
Net margin
-2.4%
The operating margin has soared by 66% YoY but it has decreased by 38% from the previous quarter
The net margin has soared by 56% YoY and by 8% QoQ
The company's operating income has surged by 51% YoY but it has shrunk by 50% QoQ
Evolent Health's net income has increased by 40% YoY and by 3.6% QoQ
Growth
What is Evolent Health's growth rate over time
Valuation
What is Evolent Health stock price valuation
P/E
N/A
P/B
1.3
P/S
0.54
EV/EBIT
N/A
EV/EBITDA
25.2
EV/Sales
0.77
The EPS rose by 10% YoY and by 3.2% QoQ
EVH's price to book (P/B) is 57% lower than its last 4 quarters average of 3.0 and 55% lower than its 5-year quarterly average of 2.9
The company's equity fell by 5% YoY
The price to sales (P/S) is 72% lower than the 5-year quarterly average of 1.9 and 64% lower than the last 4 quarters average of 1.5
The revenue has grown by 38% YoY and by 4.7% from the previous quarter
Efficiency
How efficient is Evolent Health business performance
The ROS has soared by 74% YoY
EVH's return on invested capital has surged by 64% year-on-year
Evolent Health's return on assets has increased by 13% YoY and by 2.4% QoQ
The ROE has grown by 12% YoY
Dividends
What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EVH.
Financial health
How did Evolent Health financials performed over time
The company's total assets is 96% higher than its total liabilities
The total liabilities has decreased by 9% YoY but it has increased by 3.1% from the previous quarter
The company's total assets fell by 6% YoY
The debt is 39% lower than the equity
The company's equity fell by 5% YoY
The debt has decreased by 2.8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.